Treventis treventis.com


Public list: BIO 2016 (619) Pharma Startups (4733)

Treventis is a biotechnology company focused on therapeutics and diagnostics for protein misfolding diseases. The company has leveraged a drug design platform to synthesize a class of organic drug-like molecules with the capability of binding to both beta-amyloid and tau, preventing aggregation of both proteins using a single drug. The platform for the design of small molecule anti-misfolding agents enables drug discovery for programs in Alzheimer's, Parkinson's, ALS, and other neurodegenerative...Show all

Treventis is a biotechnology company focused on therapeutics and diagnostics for protein misfolding diseases. The company has leveraged a drug design platform to synthesize a class of organic drug-like molecules with the capability of binding to both...Show all

Company (Alive / Active)

Phone: 416-603-5800 x 2975

Fax:

60 Leonard Ave 4KD472

Toronto, M5T 0S8
Ontario, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Treventis $4.4M Feb 1, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Treventis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-amyloid compounds containing benzofurazan Feb 27, 2015 Apr 10, 2018 Patent
Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine Aug 28, 2009 Apr 16, 2013 Patent
Compounds and methods for treating protein folding disorders Nov 19, 2007 Jan 29, 2013 Patent
Methods for identifying inhibitors of amyloid protein aggregation May 16, 2016 Application